All Stories

  1. Xeno-learning: knowledge transfer across species in deep learning-based spectral image analysis

    Article • Nature Biomedical Engineering, January 2026, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  2. Early-detection and prevention effects of screening sigmoidoscopy: evidence from randomized trials revisited

    Article • JNCI Journal of the National Cancer Institute, October 2025, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  3. Variable Selection via Fused Sparse‐Group Lasso Penalized Multi‐state Models Incorporating Molecular Data

    Article • Biometrical Journal, October 2025, Wiley

    Dr Annette Kopp-Schneider

  4. Quality Assured: Rethinking Annotation Strategies in Imaging AI

    Article • October 2024, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  5. Robust incorporation of historical information with known type I error rate inflation

    Article • Biometrical Journal, December 2023, Wiley

    Dr Annette Kopp-Schneider

  6. Simulating and reporting frequentist operating characteristics of clinical trials that borrow external information: Towards a fair comparison in case of one‐arm and hybrid control two‐arm trials

    Article • Pharmaceutical Statistics, August 2023, Wiley

    Dr Annette Kopp-Schneider

  7. Labelling instructions matter in biomedical image analysis

    Article • Nature Machine Intelligence, March 2023, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  8. Bovine meat and milk factor protein expression in tumor‐free mucosa of colorectal cancer patients coincides with macrophages and might interfere with patient survival

    Article • Molecular Oncology, February 2023, Wiley

    Dr Annette Kopp-Schneider

  9. MicroRNAs affecting the susceptibility of melanoma cells to CD8+ T cell‐mediated cytolysis

    Article • Clinical and Translational Medicine, January 2023, Wiley

    Dr Annette Kopp-Schneider

  10. Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORM

    Article • npj Precision Oncology, December 2022, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  11. Application of the long axial field-of-view PET/CT with low-dose [18F]FDG in melanoma

    Article • European Journal of Pediatrics, December 2022, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  12. Frequent Whole Blood Donations Select for DNMT3A variants Mediating Enhanced Response to Erythropoietin

    Article • Blood, November 2022, American Society of Hematology

    Dr Annette Kopp-Schneider

  13. Efficacy and Safety of a Personalized Vitamin D3 Loading Dose Followed by Daily 2000 IU in Colorectal Cancer Patients with Vitamin D Insufficiency: Interim Analysis of a Randomized Controlled Trial

    Article • Nutrients, October 2022, MDPI AG

    Dr Annette Kopp-Schneider

  14. Performance of phase‐I dose finding designs with and without a run‐in intra‐patient dose escalation stage

    Article • Pharmaceutical Statistics, October 2022, Wiley

    Dr Annette Kopp-Schneider

  15. Frequent whole blood donations select for DNMT3A variants mediating enhanced response to erythropoietin

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Dr Annette Kopp-Schneider

  16. Analysis of codon usage and allele frequencies reveal the double-edged nature of cross-kingdom RNAi

    Article • July 2022, Cold Spring Harbor Laboratory Press

    Dr Annette Kopp-Schneider

  17. The Medical Segmentation Decathlon

    Article • Nature Communications, July 2022, Springer Science + Business Media

    Dr Spyridon Bakas, Dr Annette Kopp-Schneider

  18. Effects of radiofrequency electromagnetic fields (RF EMF) on cancer in laboratory animal studies: A protocol for a systematic review

    Article • Environment International, March 2022, Elsevier

    Dr Annette Kopp-Schneider

  19. On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adults

    Article • Journal of Biopharmaceutical Statistics, December 2021, Taylor & Francis

    Dr Annette Kopp-Schneider

  20. Deep learning can predict lymph node status directly from histology in colorectal cancer

    Article • European Journal of Cancer, November 2021, Elsevier

    Dr Annette Kopp-Schneider

  21. Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea

    Article • Haematologica, October 2021, Ferrata Storti Foundation (Haematologica)

    Dr Annette Kopp-Schneider

  22. The prognostic significance of [18F]FDG PET/CT in multiple myeloma according to novel interpretation criteria (IMPeTUs)

    Article • EJNMMI Research, October 2021, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  23. Assessment of early metabolic progression in melanoma patients under immunotherapy: an 18F-FDG PET/CT study

    Article • EJNMMI Research, September 2021, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  24. The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets

    Article • Cancer Discovery, August 2021, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  25. Equilibrium radionuclide angiography: Intra- and inter-observer repeatability and reproducibility in the assessment of cardiac systolic and diastolic function

    Article • Journal of Nuclear Cardiology, August 2021, Elsevier

    Dr Annette Kopp-Schneider

  26. Author Correction: Methods and open-source toolkit for analyzing and visualizing challenge results

    Article • Scientific Reports, May 2021, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  27. Comparative validation of multi-instance instrument segmentation in endoscopy: Results of the ROBUST-MIS 2019 challenge

    Article • Medical Image Analysis, May 2021, Elsevier

    Debesh Jha, Dr Annette Kopp-Schneider

  28. Heidelberg colorectal data set for surgical data science in the sensor operating room

    Article • Scientific Data, April 2021, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  29. Quantitative Dynamic 18F-FDG PET/CT in Survival Prediction of Metastatic Melanoma under PD-1 Inhibitors

    Article • Cancers, March 2021, MDPI AG

    Dr Annette Kopp-Schneider

  30. An R-shiny application to calculate optimal designs for single substance and interaction trials in dose response experiments

    Article • Toxicology Letters, February 2021, Elsevier

    Dr Annette Kopp-Schneider

  31. Comparison of observation-based and model-based identification of alert concentrations from concentration–expression data

    Article • Bioinformatics, January 2021, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  32. Methods and open-source toolkit for analyzing and visualizing challenge results

    Article • Scientific Reports, January 2021, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  33. Interim [18F]FDG PET/CT can predict response to anti-PD-1 treatment in metastatic melanoma

    Article • European Journal of Pediatrics, December 2020, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  34. BIAS: Transparent reporting of biomedical image analysis challenges

    Article • Medical Image Analysis, December 2020, Elsevier

    Dr Annette Kopp-Schneider

  35. Drawing statistical conclusions from experiments with multiple quantitative measurements per subject

    Article • Radiotherapy and Oncology, November 2020, Elsevier

    Dr Annette Kopp-Schneider

  36. The design heatmap: A simple visualization of ‐optimality design problems

    Article • Biometrical Journal, October 2020, Wiley

    Dr Annette Kopp-Schneider

  37. 99mTc-MAG3 Diuretic Renography: Intra- and Inter-Observer Repeatability in the Assessment of Renal Function

    Article • Diagnostics, September 2020, MDPI AG

    Dr Annette Kopp-Schneider

  38. Comments on “Incorporating historical two‐arm data in clinical trials with binary outcome: A practical approach” by Manuel Feißt, Johannes Krisam and Meinhard Kieser

    Article • Pharmaceutical Statistics, September 2020, Wiley

    Dr Annette Kopp-Schneider

  39. Protocol of the VICTORIA study: personalized vitamin D supplementation for reducing or preventing fatigue and enhancing quality of life of patients with colorectal tumor - randomized intervention trial

    Article • BMC Cancer, August 2020, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  40. A decision-theoretic approach to Bayesian clinical trial design and evaluation of robustness to prior-data conflict

    Article • Biostatistics, July 2020, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  41. INFORM2 NivEnt: The first trial of the INFORM2 biomarker driven phase I/II trial series: the combination of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies

    Article • BMC Cancer, June 2020, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  42. Magnetic Resonance Imaging Detects Chronic Rhinosinusitis in Infants and Preschool Children with Cystic Fibrosis

    Article • Annals of the American Thoracic Society, June 2020, American Thoracic Society

    Dr Annette Kopp-Schneider

  43. Can 18F-NaF PET/CT before Autologous Stem Cell Transplantation Predict Survival in Multiple Myeloma?

    Article • Cancers, May 2020, MDPI AG

    Dr Annette Kopp-Schneider

  44. A perivascular niche in the bone marrow hosts quiescent and proliferating tumorigenic colorectal cancer cells

    Article • International Journal of Cancer, March 2020, Wiley

    Dr Annette Kopp-Schneider

  45. Exploratory identification of predictive biomarkers in randomized trials with normal endpoints

    Article • Statistics in Medicine, December 2019, Wiley

    Dr Annette Kopp-Schneider

  46. Modeling dose–response functions for combination treatments with log-logistic or Weibull functions

    Article • Archives of Toxicology, November 2019, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  47. Targeted Therapy in Advanced Melanoma With Rare BRAF Mutations

    Article • Journal of Clinical Oncology, November 2019, American Society of Clinical Oncology (ASCO)

    Dr Annette Kopp-Schneider

  48. Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs

    Article • PLOS One, September 2019, PLOS

    Dr Annette Kopp-Schneider

  49. A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice

    Article • BMC Cancer, September 2019, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  50. How to evaluate agreement between quantitative measurements

    Article • Radiotherapy and Oncology, September 2019, Elsevier

    Dr Annette Kopp-Schneider

  51. Model-based estimation of lowest observed effect concentration from replicate experiments to identify potential biomarkers of in vitro neurotoxicity

    Article • Archives of Toxicology, July 2019, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  52. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control

    Article • Biometrical Journal, July 2019, Wiley

    Dr Annette Kopp-Schneider

  53. Corrigendum: Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

    Article • Frontiers in Genetics, June 2019, Frontiers

    Dr Annette Kopp-Schneider

  54. INFORM2 exploratory multinational phase I/II combination study of nivolumab and entinostat in children and adolescents with refractory high-risk malignancies: INFORM2 NivEnt.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Dr Annette Kopp-Schneider

  55. Effect of a Single Aspirin Dose Prior to Fecal Immunochemical Testing on Test Sensitivity for Detecting Advanced Colorectal Neoplasms

    Article • JAMA, May 2019, American Medical Association (AMA)

    Dr Annette Kopp-Schneider

  56. 18F-FDG PET/CT longitudinal studies in patients with advanced metastatic melanoma for response evaluation of combination treatment with vemurafenib and ipilimumab

    Article • Melanoma Research, April 2019, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  57. Associations of diet and lifestyle factors with common volatile organic compounds in exhaled breath of average-risk individuals

    Article • Journal of Breath Research, March 2019, Institute of Physics Publishing

    Dr. Inese Polaka, Dr Annette Kopp-Schneider

  58. Quantitative dynamic 18F-fluorodeoxyglucose positron emission tomography/computed tomography before autologous stem cell transplantation predicts survival in multiple myeloma

    Article • Haematologica, February 2019, Ferrata Storti Foundation (Haematologica)

    Dr Annette Kopp-Schneider

  59. Author Correction: Why rankings of biomedical image analysis competitions should be interpreted with care

    Article • Nature Communications, January 2019, Springer Science + Business Media

    Prof Alejandro F Frangi, Dr Annette Kopp-Schneider

  60. Persistence of Epigenomic Effects After Recovery From Repeated Treatment With Two Nephrocarcinogens

    Article • Frontiers in Genetics, December 2018, Frontiers

    Dr Annette Kopp-Schneider

  61. Why rankings of biomedical image analysis competitions should be interpreted with care

    Article • Nature Communications, December 2018, Springer Science + Business Media

    Prof Alejandro F Frangi, Dr Annette Kopp-Schneider

  62. GOLD stage predicts thoracic aortic calcifications in patients with COPD

    Article • Experimental and Therapeutic Medicine, November 2018, Spandidos Publications

    Dr Annette Kopp-Schneider

  63. Can benign lymphoid tissue changes in 18F-FDG PET/CT predict response to immunotherapy in metastatic melanoma?

    Article • Medical Oncology, November 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  64. Investigation of Nrf2, AhR and ATF4 Activation in Toxicogenomic Databases

    Article • Frontiers in Genetics, October 2018, Frontiers

    Dr Annette Kopp-Schneider

  65. Clinical trial protocol of the ASTER trial: a double-blind, randomized, placebo-controlled phase III trial evaluating the use of acetylsalicylic acid (ASA) for enhanced early detection of colorectal neoplasms

    Article • BMC Cancer, September 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  66. Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approach

    Article • Biometrical Journal, September 2018, Wiley

    Dr Annette Kopp-Schneider

  67. Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT

    Article • Medical Oncology, June 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  68. BRAF/MEK inhibition in melanoma patients with rare BRAF mutations.

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Dr Annette Kopp-Schneider

  69. Omics-based responses induced by bosentan in human hepatoma HepaRG cell cultures

    Article • Archives of Toxicology, May 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  70. Exploiting the potential of unlabeled endoscopic video data with self-supervised learning

    Article • International Journal of Computer Assisted Radiology and Surgery, April 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  71. Assessment of glucose metabolism and cellular proliferation in multiple myeloma: a first report on combined 18F-FDG and 18F-FLT PET/CT imaging

    Article • EJNMMI Research, April 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  72. The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma

    Article • European Journal of Pediatrics, February 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  73. The European water-based environmental quality standard for pentachlorophenol is NOT protective of benthic organisms

    Article • The Science of The Total Environment, February 2018, Elsevier

    Dr Annette Kopp-Schneider

  74. 68Ga-PSMA PET/CT in the evaluation of bone metastases in prostate cancer

    Article • European Journal of Pediatrics, January 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  75. How to Exploit Weaknesses in Biomedical Challenge Design and Organization

    Article • January 2018, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  76. Optimal experimental designs for estimating the drug combination index in toxicology

    Article • Computational Statistics & Data Analysis, January 2018, Elsevier

    Dr Annette Kopp-Schneider

  77. Multiple-rater kappas for binary data: Models and interpretation

    Article • Biometrical Journal, December 2017, Wiley

    Dr Annette Kopp-Schneider

  78. Clustering of samples and variables with mixed-type data

    Article • PLOS One, November 2017, PLOS

    Dr Annette Kopp-Schneider

  79. Parametric modeling and optimal experimental designs for estimating isobolograms for drug interactions in toxicology

    Article • Journal of Biopharmaceutical Statistics, November 2017, Taylor & Francis

    Dr Annette Kopp-Schneider

  80. Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab

    Article • European Journal of Pediatrics, November 2017, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  81. Prediction of clinical response to drugs in ovarian cancer using the chemotherapy resistance test (CTR-test)

    Article • Journal of Ovarian Research, October 2017, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  82. Maximum intensity breast diffusion MRI for BI-RADS 4 lesions detected on X-ray mammography

    Article • Clinical Radiology, October 2017, Elsevier

    Dr Annette Kopp-Schneider

  83. Omics-based in vitro verification of an adverse outcome pathway of cholestatic liver injury

    Article • Toxicology Letters, October 2017, Elsevier

    Dr Annette Kopp-Schneider

  84. Testing R Code R. Cotton  Boca Raton, FL: Chapman & Hall/CRC Press. 178 pages, ISBN 978-1-4987-6365-3

    Article • Biometrical Journal, September 2017, Wiley

    Dr Annette Kopp-Schneider

  85. Addressing small sample size bias in multiple-biomarker trials: Inclusion of biomarker-negative patients and Firth correction

    Article • Biometrical Journal, August 2017, Wiley

    Dr Annette Kopp-Schneider

  86. Prediction accuracy and variable selection for penalized cause-specific hazards models

    Article • Biometrical Journal, August 2017, Wiley

    Dr Annette Kopp-Schneider

  87. Chemosensitivity-directed therapy compared to dacarbazine in chemo-naive advanced metastatic melanoma: a multicenter randomized phase-3 DeCOG trial

    Article • Oncotarget, June 2017, Impact Journals, LLC

    Dr Annette Kopp-Schneider

  88. Dissecting and modeling the emergent murine TEC compartment during ontogeny

    Article • European Journal of Immunology, May 2017, Wiley

    Dr Annette Kopp-Schneider

  89. Heterogeneous treatment effects in stratified clinical trials with time‐to‐event endpoints

    Article • Biometrical Journal, March 2017, Wiley

    Dr Annette Kopp-Schneider

  90. Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival

    Article • Cell Death and Disease, March 2017, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  91. Newin vitrosystem to predict chemotherapeutic efficacy of drug combinations in fresh tumor samples

    Article • PeerJ, March 2017, PeerJ

    Dr Annette Kopp-Schneider

  92. Epstein–Barr virus particles induce centrosome amplification and chromosomal instability

    Article • Nature Communications, February 2017, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  93. The biological properties of different Epstein-Barr virus strains explain their association with various types of cancers

    Article • Oncotarget, December 2016, Impact Journals, LLC

    Dr Annette Kopp-Schneider

  94. Abstract B77: CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

    Article • Cancer Research, December 2016, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  95. Functional analysis of high-content high-throughput imaging data

    Article • Journal of Applied Statistics, September 2016, Taylor & Francis

    Dr Annette Kopp-Schneider

  96. MYCN and HDAC5 transcriptionally repress CD9 to trigger invasion and metastasis in neuroblastoma

    Article • Oncotarget, August 2016, Impact Journals, LLC

    Dr Annette Kopp-Schneider

  97. Use of LDH and Autoimmune Side Effects to Predict Response to Ipilimumab Treatment

    Article • Immunotherapy, August 2016, Taylor & Francis

    Dr Annette Kopp-Schneider

  98. “Watching the Detectives” report of the general assembly of the EU project DETECTIVE Brussels, 24–25 November 2015

    Article • Archives of Toxicology, April 2016, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  99. Differences in the carcinogenic evaluation of glyphosate between the International Agency for Research on Cancer (IARC) and the European Food Safety Authority (EFSA)

    Article • Journal of Epidemiology & Community Health, March 2016, BMJ

    Professor Lin Fritschi, Dr Annette Kopp-Schneider

  100. CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma

    Article • Nature Reports Stem Cells, February 2016, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  101. Tubular Dickkopf-3 promotes the development of renal atrophy and fibrosis

    Article • JCI Insight, January 2016, American Society for Clinical Investigation

    Dr Annette Kopp-Schneider

  102. Cell type-specific expression and localization of cytochrome P450 isoforms in tridimensional aggregating rat brain cell cultures

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  103. Quantitative in vitro to in vivo extrapolation of tissues toxicity

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  104. Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  105. Transcriptomics hit the target: Monitoring of ligand-activated and stress response pathways for chemical testing

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  106. Application of RPTEC/TERT1 cells for investigation of repeat dose nephrotoxicity: A transcriptomic study

    Article • Toxicology in Vitro, December 2015, Elsevier

    Dr Annette Kopp-Schneider

  107. Comparison of hybrid 68Ga-PSMA PET/MRI and 68Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer

    Article • European Journal of Pediatrics, October 2015, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  108. Selective inhibition of HDAC8 decreases neuroblastoma growth in vitro and in vivo and enhances retinoic acid-mediated differentiation

    Article • Cell Death and Disease, February 2015, Nature

    Dr Annette Kopp-Schneider

  109. Richly Parametrized Linear Models: Additive, Time Series, and Spatial Models Using Random Effects. J. S. Hodges (2014). Boca Raton: Chapman & Hall/CRC Texts in Statistical Science. 431 pages, ISBN: 978-1-4398-6683-2.

    Article • Biometrical Journal, October 2014, Wiley

    Dr Annette Kopp-Schneider

  110. Statistical strategies for averaging EC50 from multiple dose–response experiments

    Article • Archives of Toxicology, October 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  111. A sphingosine kinase inhibitor combined with temozolomide induces glioblastoma cell death through accumulation of dihydrosphingosine and dihydroceramide, endoplasmic reticulum stress and autophagy

    Article • Cell Death and Disease, September 2014, Nature

    Dr Annette Kopp-Schneider

  112. Quantitative Emphysema Distribution in Anatomic and Non-anatomic Lung Regions

    Article • COPD Journal of Chronic Obstructive Pulmonary Disease, September 2014, Taylor & Francis

    Dr Annette Kopp-Schneider

  113. Integration of transcriptomic, epigenomic, proteomic and metabolomic data for the characterisation of the molecular response of renal epithelial cells to repeat-dose exposure to chemicals in vitro

    Article • Toxicology Letters, September 2014, Elsevier

    Dr Annette Kopp-Schneider

  114. Optimal experimental designs for dose–response studies with continuous endpoints

    Article • Archives of Toxicology, August 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  115. Reproducible Research with R and RStudio. C. Gandrud (2013). Chapman & Hall/CRC: The R Series. 294 pages, ISBN-13: 978-1466572843.

    Article • Biometrical Journal, May 2014, Wiley

    Dr Annette Kopp-Schneider

  116. Genomic Clinical Trials and Predictive Medicine. R. M. Simon (2013). New York: Cambridge University Press. 144 pages, ISBN: 978-1-107-40135-8.

    Article • Biometrical Journal, May 2014, Wiley

    Dr Annette Kopp-Schneider

  117. Magnetic Resonance Imaging Detects Changes in Structure and Perfusion, and Response to Therapy in Early Cystic Fibrosis Lung Disease

    Article • American Review of Respiratory Disease, April 2014, American Thoracic Society

    Dr Annette Kopp-Schneider

  118. Erratum to: Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla

    Article • European Radiology, February 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  119. Summarizing EC50 estimates from multiple dose-response experiments: A comparison of a meta-analysis strategy to a mixed-effects model approach

    Article • Biometrical Journal, January 2014, Wiley

    Dr Annette Kopp-Schneider

  120. GRHL1 Acts as Tumor Suppressor in Neuroblastoma and Is Negatively Regulated by MYCN and HDAC3

    Article • Cancer Research, January 2014, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  121. Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis

    Article • Radiation Oncology, January 2014, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  122. Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience

    Article • European Journal of Pediatrics, December 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  123. Validation of Fourier decomposition MRI with dynamic contrast-enhanced MRI using visual and automated scoring of pulmonary perfusion in young cystic fibrosis patients

    Article • European Journal of Radiology, December 2013, Elsevier

    Dr Annette Kopp-Schneider

  124. Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla

    Article • European Radiology, October 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  125. Transcriptomic Hepatotoxicity Signature of Chlorpromazine after Short- and Long-Term Exposure in Primary Human Sandwich Cultures

    Article • Drug Metabolism and Disposition, August 2013, American Society for Pharmacology & Experimental Therapeutics (ASPET)

    Dr Annette Kopp-Schneider

  126. Predict-IV project overview (EU grant 202222): non animal-based toxicity profiling by integrating toxico dynamics and biokinetics

    Article • Toxicology Letters, August 2013, Elsevier

    Dr Annette Kopp-Schneider

  127. Comparative analysis of eight cytotoxicity assays evaluated within the ACuteTox Project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  128. Data management in large-scale collaborative toxicity studies: How to file experimental data for automated statistical analysis

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  129. Design of a testing strategy using non-animal based test methods: Lessons learnt from the ACuteTox project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  130. Evaluation of aggregating brain cell cultures for the detection of acute organ-specific toxicity

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  131. Selection of test methods to be included in a testing strategy to predict acute oral toxicity: An approach based on statistical analysis of data collected in phase 1 of the ACuteTox project

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  132. The value of selected in vitro and in silico methods to predict acute oral toxicity in a regulatory context: Results from the European Project ACuteTox

    Article • Toxicology in Vitro, June 2013, Elsevier

    Dr Annette Kopp-Schneider

  133. MYCN and HDAC2 cooperate to repress miR-183 signaling in neuroblastoma

    Article • Nucleic Acids Research, April 2013, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  134. Biological and Tumor-Promoting Effects of Dioxin-like and Non-Dioxin-like Polychlorinated Biphenyls in Mouse Liver After Single or Combined Treatment

    Article • Toxicological Sciences, March 2013, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  135. Accuracy and Variability of Semiautomatic Centerline Analysis versus Manual Aortic Measurement Techniques for TEVAR

    Article • European Journal of Vascular and Endovascular Surgery, March 2013, Elsevier

    Dr Annette Kopp-Schneider

  136. Diffusion-weighted imaging in rectal carcinoma patients without and after chemoradiotherapy: A comparative study with histology

    Article • European Journal of Radiology, March 2013, Elsevier

    Dr Annette Kopp-Schneider

  137. Stochastic time‐concentration activity models for cytotoxicity in 3D brain cell cultures

    Article • Theoretical Biology and Medical Modelling, January 2013, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  138. The role of perfusion effects in monitoring of chemoradiotherapy of rectal carcinoma using diffusion-weighted imaging

    Article • Cancer Imaging, January 2013, E-MED LTD

    Dr Annette Kopp-Schneider

  139. Natural variants in the major neutralizing epitope of human papillomavirus minor capsid protein L2

    Article • International Journal of Cancer, October 2012, Wiley

    Dr Annette Kopp-Schneider

  140. The impact of data transformations on concentration–response modeling

    Article • Toxicology Letters, September 2012, Elsevier

    Dr Annette Kopp-Schneider

  141. Report of the EPAA–ECVAM Workshop on the Validation of Integrated Testing Strategies (ITS)

    Article • Alternatives to Laboratory Animals, July 2012, SAGE Publications

    Dr Annette Kopp-Schneider

  142. Accuracy of MRI with an endorectal coil for staging endometrial cancer

    Article • Acta Radiologica, June 2012, SAGE Publications

    Dr Annette Kopp-Schneider

  143. Morphologic and functional scoring of cystic fibrosis lung disease using MRI

    Article • European Journal of Radiology, June 2012, Elsevier

    Dr Annette Kopp-Schneider

  144. Proposal for a New Prognostic Score for Linac-Based Radiosurgery in Cerebral Arteriovenous Malformations

    Article • International Journal of Radiation Oncology*Biology*Physics, June 2012, Elsevier

    Dr Annette Kopp-Schneider

  145. On the identification of predictive biomarkers: Detecting treatment-by-gene interaction in high-dimensional data

    Article • Computational Statistics & Data Analysis, May 2012, Elsevier

    Dr Annette Kopp-Schneider

  146. Clinical phase I/II trial to investigate neoadjuvant intensity-modulated short term radiation therapy (5 × 5 gy) and intraoperative radiation therapy (15 gy) in patients with primarily resectable pancreatic cancer - NEOPANC

    Article • BMC Cancer, March 2012, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  147. Epstein-Barr Virus Stimulates Torque Teno Virus Replication: A Possible Relationship to Multiple Sclerosis

    Article • PLOS One, February 2012, PLOS

    Dr Annette Kopp-Schneider

  148. An Adaptive Group Sequential Phase II Design to Compare Treatments for Survival Endpoints in Rare Patient Entities

    Article • Journal of Biopharmaceutical Statistics, January 2012, Taylor & Francis

    Dr Annette Kopp-Schneider

  149. Multimodal hypoxia imaging and intensity modulated radiation therapy for unresectable non-small-cell lung cancer: the HIL trial

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  150. The Feasibility of Low Mechanical Index Contrast Enhanced Ultrasound (CEUS) in Distinguishing Malignant from Benign Thoracic Lesions

    Article • Ultrasound in Medicine & Biology, November 2011, Elsevier

    Dr Annette Kopp-Schneider

  151. High-resolution phase-contrast MRI of aortic and pulmonary blood flow during rest and physical exercise using a MRI compatible bicycle ergometer

    Article • European Journal of Radiology, October 2011, Elsevier

    Dr Annette Kopp-Schneider

  152. Repeatability and Reproducibility of Quantitative Whole-lung Perfusion Magnetic Resonance Imaging

    Article • Journal of Thoracic Imaging, August 2011, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  153. Concordance Analysis

    Article • Deutsches Ärzteblatt international, July 2011, Deutscher Arzte-Verlag GmbH

    Dr Annette Kopp-Schneider

  154. E6 and E7 from Beta Hpv38 Cooperate with Ultraviolet Light in the Development of Actinic Keratosis-Like Lesions and Squamous Cell Carcinoma in Mice

    Article • PLoS Pathogens, July 2011, PLOS

    Dr Annette Kopp-Schneider

  155. Robust biclustering by sparse singular value decomposition incorporating stability selection

    Article • Bioinformatics, June 2011, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  156. Fine Tuning of the Threshold of T Cell Selection by the Nck Adapters

    Article • The Journal of Immunology, November 2010, The American Association of Immunologists

    Dr Annette Kopp-Schneider

  157. Glossopharyngeal Insufflation and Pulmonary Hemodynamics in Elite Breath Hold Divers

    Article • Medicine & Science in Sports & Exercise, September 2010, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  158. Nck adaptors are positive regulators of the size and sensitivity of the T-cell repertoire

    Article • Proceedings of the National Academy of Sciences, August 2010, Proceedings of the National Academy of Sciences

    Dr Annette Kopp-Schneider

  159. Optimization and prevalidation of the in vitro ERα CALUX method to test estrogenic and antiestrogenic activity of compounds

    Article • Reproductive Toxicology, August 2010, Elsevier

    Dr Annette Kopp-Schneider

  160. Time- and Dose-Dependency of Radiographic Normal Tissue Changes of the Lung After Stereotactic Radiotherapy

    Article • International Journal of Radiation Oncology*Biology*Physics, August 2010, Elsevier

    Dr Annette Kopp-Schneider

  161. Presentation And Reproducibility Of A New Morphological And Functional Scoring System For Magnetic Resonance Imaging In Cystic Fibrosis

    Article • May 2010, American Thoracic Society

    Dr Annette Kopp-Schneider

  162. HDAC5 and HDAC9 in Medulloblastoma: Novel Markers for Risk Stratification and Role in Tumor Cell Growth

    Article • Clinical Cancer Research, April 2010, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  163. Application of a two-phenotype color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment

    Article • Mathematical Biosciences, April 2010, Elsevier

    Dr Annette Kopp-Schneider

  164. Modelling the genesis and treatment of cancer: The potential role of physiologically based pharmacodynamics

    Article • European Journal of Cancer, January 2010, Elsevier

    Dr Annette Kopp-Schneider

  165. 4D-CT-based target volume definition in stereotactic radiotherapy of lung tumours: Comparison with a conventional technique using individual margins

    Article • Radiotherapy and Oncology, December 2009, Elsevier

    Dr Annette Kopp-Schneider

  166. Toxicogenomic analysis of N-nitrosomorpholine induced changes in rat liver: Comparison of genomic and proteomic responses and anchoring to histopathological parameters

    Article • Toxicology and Applied Pharmacology, December 2009, Elsevier

    Dr Annette Kopp-Schneider

  167. Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI

    Article • European Radiology, September 2009, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  168. “ToxRTool”, a new tool to assess the reliability of toxicological data

    Article • Toxicology Letters, September 2009, Elsevier

    Dr Annette Kopp-Schneider

  169. Respiratory Displacement of the Thoracic Aorta: Physiological Phenomenon With Potential Implications for Thoracic Endovascular Repair

    Article • Cardiovascular Radiology, May 2009, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  170. Changes of prostate gland volume with and without androgen deprivation after intensity modulated radiotherapy – A follow-up study

    Article • Radiotherapy and Oncology, March 2009, Elsevier

    Dr Annette Kopp-Schneider

  171. Histone deacetylases 5 and 9 are novel markers for medulloblastoma risk stratification and potential drug targets for therapy

    Article • Klinische Pädiatrie, March 2009, Thieme Publishing Group

    Dr Annette Kopp-Schneider

  172. Histone Deacetylase 8 in Neuroblastoma Tumorigenesis

    Article • Clinical Cancer Research, January 2009, American Association for Cancer Research (AACR)

    Dr Annette Kopp-Schneider

  173. Morphology, metabolism, microcirculation, and strength of skeletal muscles in cancer-related cachexia

    Article • Acta Oncologica, January 2009, Taylor & Francis

    Dr Annette Kopp-Schneider

  174. Intrinsic Gating for Small-Animal Computed Tomography: A Robust ECG-Less Paradigm for Deriving Cardiac Phase Information and Functional Imaging

    Article • Circulation Cardiovascular Imaging, November 2008, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  175. Assessment of thoracic aortic conformational changes by four-dimensional computed tomography angiography in patients with chronic aortic dissection type b

    Article • European Radiology, July 2008, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  176. Anti-neuroblastoma activity of Helminthosporium carbonum (HC)-toxin is superior to that of other differentiating compounds in vitro

    Article • Cancer Letters, June 2008, Elsevier

    Dr Annette Kopp-Schneider

  177. Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III/IV-A feasibility study

    Article • European Radiology, February 2008, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  178. Ganganalyse bei extremitätenerhaltender Tumorchirurgie - Vergleich der Bewegungsmuster nach Resektion primär maligner Tumoren im Bereich des Kniegelenkes

    Article • Zeitschrift für Orthopädie und Unfallchirurgie, December 2007, Thieme Publishing Group

    Dr Annette Kopp-Schneider

  179. Magnetic resonance-compatible-spirometry: principle, technical evaluation and application

    Article • European Respiratory Journal, November 2007, European Respiratory Society (ERS)

    Dr Annette Kopp-Schneider

  180. C4.4A as a candidate marker in the diagnosis of colorectal cancer

    Article • British Journal of Cancer, October 2007, Nature

    Dr Annette Kopp-Schneider

  181. Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis (CF) Patients

    Article • Investigative Radiology, October 2007, Wolters Kluwer Health

    Dr Annette Kopp-Schneider

  182. Comparison of Mode of Action of Four Hepatocarcinogens: A Model-Based Approach

    Article • Toxicological Sciences, May 2007, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  183. TTV infection in colorectal cancer tissues and normal mucosa

    Article • International Journal of Cancer, January 2007, Wiley

    Dr Annette Kopp-Schneider

  184. E6/E7 Expression of Human Papillomavirus Type 20 (HPV-20) and HPV-27 Influences Proliferation and Differentiation of the Skin in UV-Irradiated SKH-hr1 Transgenic Mice

    Article • Journal of Virology, September 2006, ASM Journals

    Dr Annette Kopp-Schneider

  185. Application of a color-shift model with heterogeneous growth to a rat hepatocarcinogenesis experiment

    Article • Mathematical Biosciences, August 2006, Elsevier

    Dr Annette Kopp-Schneider

  186. Investigating the Formation and Growth of α-Particle Radiation-Induced Foci of Altered Hepatocytes: A Model-Based Approach

    Article • Radiation Research, August 2006, Radiation Research Society

    Dr Annette Kopp-Schneider

  187. Comparison of Software Tools to Improve the Detection of Carcinogen Induced Changes in the Rat Liver Proteome by Analyzing SELDI-TOF−MS Spectra

    Article • Journal of Proteome Research, February 2006, American Chemical Society (ACS)

    Dr Annette Kopp-Schneider

  188. Serological analysis of human renal cell carcinoma

    Article • International Journal of Cancer, January 2006, Wiley

    Dr Annette Kopp-Schneider

  189. Reduced Expression of Interleukin-2 Decreases the Frequency of Alopecia Areata Onset in C3H/HeJ Mice

    Article • Journal of Investigative Dermatology, November 2005, Elsevier

    Dr Annette Kopp-Schneider

  190. Origins of the mutational origin of cancer

    Article • International Journal of Epidemiology, July 2005, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  191. Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

    Article • Oncology Research and Treatment, June 2005, Karger Publishers

    Dr Annette Kopp-Schneider

  192. Molecular approaches to the identification of biomarkers of exposure and effect—report of an expert meeting organized by COST Action B15

    Article • Toxicology Letters, April 2005, Elsevier

    Dr Annette Kopp-Schneider

  193. Differential signatures of protein expression in marmoset liver and thymus induced by single-dose TCDD treatment

    Article • Toxicology, January 2005, Elsevier

    Dr Annette Kopp-Schneider

  194. Increased Incidence of Squamous Cell Carcinomas in Mastomys natalensis Papillomavirus E6 Transgenic Mice during Two-Stage Skin Carcinogenesis

    Article • Journal of Virology, May 2004, ASM Journals

    Dr Annette Kopp-Schneider

  195. Randomized Clinical Trial: Myths around Elementary Statistical Principles

    Article • Oncology Research and Treatment, January 2004, Karger Publishers

    Dr Annette Kopp-Schneider

  196. Visualization of Parametric Carcinogenesis Models

    Article • January 2004, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  197. Biostatistical Evaluation of Focal Hepatic Preneoplasia

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  198. Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  199. Biostatistical Evaluation of Focal Hepatic Preneoplasia

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  200. Prevalidation of a Rat Liver Foci Bioassay (RLFB) Based on Results from 1600 Rats: A Study Report

    Article • Toxicologic Pathology, January 2003, SAGE Publications

    Dr Annette Kopp-Schneider

  201. Deviation from Additivity in Mixture Toxicity: Relevance of Nonlinear Dose-Response Relationships and Cell Line Differences in Genotoxicity Assays with Combinations of Chemical Mutagens and -Radiation

    Article • Environmental Health Perspectives, December 2002, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  202. Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

    Article • Oncology Research and Treatment, November 2002, Karger Publishers

    Dr Annette Kopp-Schneider

  203. Woodchuck hepatitis virus replication and antigen expression gradually decrease in preneoplastic hepatocellular lineages

    Article • Journal of Hepatology, October 2002, Elsevier

    Dr Annette Kopp-Schneider

  204. Incorporating phenotype-dependent growth rates into the color-shift model for preneoplastic hepatocellular lesions

    Article • Mathematical Biosciences, September 2002, Elsevier

    Dr Annette Kopp-Schneider

  205. Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization

    Article • British Journal of Cancer, November 2001, Nature

    Dr Annette Kopp-Schneider

  206. Modeling cancer detection: tumor size as a source of information on unobservable stages of carcinogenesis

    Article • Mathematical Biosciences, June 2001, Elsevier

    Dr Annette Kopp-Schneider

  207. J-Shaped Dose-Response Relationship for Tumor Induction by Caffeic Acid in the Rat Forestomach, Modeled by Non-Monotonic Dose Response for DNA Damage and Cell Proliferation

    Article • Human and Ecological Risk Assessment An International Journal, June 2001, Taylor & Francis

    Dr Annette Kopp-Schneider

  208. Using a stochastic model to analyze the sequence of phenotypic changes in rat liver focal lesions

    Article • Mathematical and Computer Modelling, June 2001, Elsevier

    Dr Annette Kopp-Schneider

  209. Aberrant cyclooxygenase isozyme expression in human intrahepatic cholangiocarcinoma

    Article • Gut, January 2001, BMJ

    Dr Annette Kopp-Schneider

  210. A model for hepatocarcinogenesis with clonal expansion of three successive phenotypes of preneoplastic cells

    Article • Mathematical Biosciences, December 2000, Elsevier

    Dr Annette Kopp-Schneider

  211. Hepadnaviral hepatocarcinogenesis: in situ visualization of viral antigens, cytoplasmic compartmentation, enzymic patterns, and cellular proliferation in preneoplastic hepatocellular lineages in woodchucks

    Article • Journal of Hepatology, October 2000, Wiley

    Dr Annette Kopp-Schneider

  212. Multistage, stochastic models of the cancer process: A general theory for calculating tumor incidence

    Article • Stochastic Hydrology and Hydraulics, August 2000, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  213. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphism

    Article • Carcinogenesis, January 2000, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  214. Adjuvant Radio-Chemotherapy with 5-Fluorouracil and Leucovorin in Stage II and III Rectal Cancer: 12 Months vs. 6 Months of Therapy. A Study of the Association for Medical Oncology of the German Cancer Society

    Article • Oncology Research and Treatment, January 2000, Karger Publishers

    Dr Annette Kopp-Schneider

  215. Threshold dose response for tumor induction by genotoxic carcinogens modeled via cell-cycle delay

    Article • Toxicological Sciences, May 1999, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  216. Xenomorphic hepatocellular precursors and neoplastic progression of tigroid cell foci induced in rats with low doses of N-nitrosomorpholine

    Article • Carcinogenesis, December 1998, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  217. Localization of prostaglandin H synthase isoenzymes in murine epidermal tumors: Suppression of skin tumor promotion by inhibition of prostaglandin H synthase-2

    Article • Molecular Carcinogenesis, September 1998, Wiley

    Dr Annette Kopp-Schneider

  218. Statistical models for low dose exposure

    Article • Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, September 1998, Elsevier

    Dr Annette Kopp-Schneider

  219. A model for hepatocarcinogenesis treating phenotypical changes in focal hepatocellular lesions as epigenetic events

    Article • Mathematical Biosciences, March 1998, Elsevier

    Dr Annette Kopp-Schneider

  220. Carcinogenesis models for risk assessment

    Article • Statistical Methods in Medical Research, April 1997, SAGE Publications

    Dr Annette Kopp-Schneider

  221. Calculating tumor incidence rates in stochastic models of carcinogenesis

    Article • Mathematical Biosciences, July 1996, Elsevier

    Dr Annette Kopp-Schneider

  222. Modeling the Number and Size of Hepatic Focal Lesions Following Exposure to 2,3,7,8-TCDD

    Article • Toxicology and Applied Pharmacology, May 1996, Elsevier

    Dr Annette Kopp-Schneider

  223. Effects of low doses of N -nitrosomorpholine on the development of early stages of hepatocarcinogenesis

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  224. Carcinoma formation in NMRI mouse skin painting studies is a process suggesting greater than two stages

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  225. Malignant progression of papillomas induced by the initiation-promotion protocol in NMRI mouse skin

    Article • Carcinogenesis, January 1995, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  226. Multistage Models of Carcinogenesis: An Approximation for the Size and Number Distribution of Late-Stage Clones

    Article • Risk Analysis, December 1994, Wiley

    Dr Annette Kopp-Schneider

  227. The Exact Formula for Tumor Incidence in the Two-Stage Model

    Article • Risk Analysis, December 1994, Wiley

    Dr Annette Kopp-Schneider

  228. Porphyrin studies in TCDD-exposed workers

    Article • Archives of Toxicology, September 1994, Springer Science + Business Media

    Dr Annette Kopp-Schneider

  229. A stem cell model for carcinogenesis

    Article • Mathematical Biosciences, April 1994, Elsevier

    Dr Annette Kopp-Schneider

  230. Cell proliferation and cell death (apoptosis) in hepatic preneoplasia and neoplasia are closely related to phenotypic cellular diversity and instability

    Article • Carcinogenesis, January 1994, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  231. The use of cell proliferation data in modeling of skin carcinogenesis

    Article • Environmental Health Perspectives, December 1993, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  232. Using cell replication data in mathematical modeling in carcinogenesis

    Article • Environmental Health Perspectives, December 1993, Environmental Health Perspectives

    Dr Annette Kopp-Schneider

  233. The Use of Cell Proliferation Data in Modeling of Skin Carcinogenesis

    Article • Environmental Health Perspectives, December 1993, JSTOR

    Dr Annette Kopp-Schneider

  234. Using Cell Replication Data in Mathematical Modeling in Carcinogenesis

    Article • Environmental Health Perspectives, December 1993, JSTOR

    Dr Annette Kopp-Schneider

  235. Birth and death/differentiation rates of papillomas in mouse skin

    Article • Carcinogenesis, January 1992, Oxford University Press (OUP)

    Dr Annette Kopp-Schneider

  236. Birth—death processes with piecewise constant rates

    Article • Statistics & Probability Letters, January 1992, Elsevier

    Dr Annette Kopp-Schneider

  237. Distinguishing between models of carcinogenesis: The role of clonal expansion

    Article • Fundamental and Applied Toxicology, October 1991, Elsevier

    Dr Annette Kopp-Schneider

  238. A Multistage Model of Carcinogenesis Incorporating DNA Damage and Repair

    Article • Risk Analysis, September 1991, Wiley

    Dr Annette Kopp-Schneider

  239. The application of a multistage model that incorporates DNA damage and repair to the analysis of initiation/promotion experiments

    Article • Mathematical Biosciences, July 1991, Elsevier

    Dr Annette Kopp-Schneider